Kezar Life Sciences (KZR) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

KZR Kezar Life Sciences

Watchlist

7.470
-0.030-0.40%

Close Nov 25 16:00 ET

7.400
-0.070-0.94%

Pre 08:37 ET

54.50MMarket Cap-569P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

KEZAR MARKETS ANNOUNCES RETIREMENT OF CEO WHIT CONARY & NAMES STEVE MIELE AS THE NEW CHIEF EXECUTIVE OFFICER
PR NewswireNov 25 07:50 ET
Express News | Kezar Life Sciences Inc: On November 13, Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
ReutersNov 14 16:38 ET
Kezar Life Sciences Is Maintained at Equal-Weight by Wells Fargo
Dow JonesNov 14 09:31 ET · Ratings
Wells Fargo Maintains Kezar Life Sciences(KZR.US) With Hold Rating, Cuts Target Price to $11
Moomoo NewsNov 14 06:33 ET · Ratings
TD Cowen Maintains Kezar Life Sciences(KZR.US) With Buy Rating
Moomoo NewsNov 13 00:31 ET · Ratings
Kezar Life Sciences (KZR) Receives a Buy From TD Cowen
TipRanksNov 13 00:05 ET · Ratings

Comments

Jaguar8

Oct 29 22:34

RS tomorrow 1:10. Post RS float 4.5M shares

$Kezar Life Sciences (KZR.US)$

Trytosaveabit

Oct 8 15:23

Form 13

$Kezar Life Sciences (KZR.US)$ Kezar Life Sciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL MANAGEMENT, LLC(9.9%),KEVIN TANG(9.9%), etc.
SEC· just

Jaguar8

Sep 30 08:55

NEWS

$Kezar Life Sciences (KZR.US)$
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients